NCT00349167View on ClinicalTrials.gov

PR-104 in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

PR-104

OTHER

laboratory biomarker analysis

OTHER

pharmacological study

Trial Locations (1)

90095-1781

Jonsson Comprehensive Cancer Center at UCLA, Los Angeles

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Proacta, Incorporated

INDUSTRY

NCT00349167 - PR-104 in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter